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a b s t r a c t
The aim of investigation was to assess treatment outcomes in adult patients with thalamic
tumors, operated on with the aid of tractography (DTI) and monitoring of motor evoked
potentials (MEPs) generated due to transcranial electrical stimulation (TES) and direct
electrical stimulation (DES) of the subcortical white matter.
38 subsequent patients with thalamic tumorswere operated on using tractography (DTI)-
integrated neuronavigation, transcranial electrical stimulation (TES) and direct electrical
stimulation (DES). The volumetric method was used to calculate pre- and postoperative
tumor volume.
Total tumor resection (100%) was performed in 18 (47%) patients, subtotal in 9 (24%)
(mean extent of resection 89.4%) and partial in 11 (29%) patients (mean extent of resection
77.18%). The mean extent of resection for all surgical patients was 86.5%.
Two (5.2%) patients died postoperatively. Preoperative hemiparesis was present in 18
(47%) patients. Postoperative hemiparesis was observed in 11 (29%) patients of whomonly in
5 (13%) new paresis was noted due to surgical intervention. In patients with hemiparesis
signiﬁcantly more frequently larger tumor volume was detected preoperatively. Low mean
normal fractional anisotropy (nFA) values in the internal capsule were observed statistically
signiﬁcantly more frequently in patients with preoperative hemiparesis as compared to the
internal capsule of the unaffected hemisphere. Transcranial electrical stimulation helps to
predict postoperative paresis of extremities. Direct electrical stimulation is an effective tool
for intraoperative localization of the internal capsule thus helping to avoid postoperative
deﬁcit.
In patients with tumor grade I and II the median time to tumor progression was 36
months. In the case of patients with grades III and IV it was 14months. Themedian survival
time in patients with grades I and II it was 60months. In patientswith grades III and IV it was
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[143_TD$DIFF] . Introduction
Thalamic gliomas are extremely rare brain tumors [1–4]. Such
gliomas are themost prevalent among children or adolescents
and after the age of 40 as WHO grade III or IV tumors. Surgical
treatment of thalamic tumors is associated with the risk of
hemiparesis and/or hemianopia [5–9]. Furthermore, patients
whose tumors are locatedwithin a dominant hemispheremay
suffer from postoperative speech disorders.
Children and adolescents present with thalamic glial
tumors of different nature than those found in adults
[5,7,9,10,11]. Pilocytic astrocytoma is the most common
thalamic glial tumor diagnosed in children. This tumor is
well demarcated from the surrounding tissues and causes
distortion of adjacent anatomical structures. The prognosis is
favorable provided that total resection of the lesion is
performed. Pilocytic astrocytoma does not usually inﬁltrate
the surrounding neural structures [10–12]. The most common
types of thalamic glial tumors diagnosed in adults are
anaplastic astrocytoma and glioblastoma multiforme
[5,9,11]. Due to inﬁltration of the surrounding anatomical
structures and rapid progression, prognosis in patients with
these tumors is generally poor [5,9,11].
Low-grade gliomas of the thalamus are considerably less
common in other locations, e.g. in the insula [9]. The thalamic
lesion frequently involves also posterior and mesencephalic
peduncles (as the so-called thalamopeduncular tumor) [9,12].
Total resection of such tumor may be hindered due to the
presence of the corticospinal tract ﬁbers within the mass [13].
In order to minimize the risk of severe postoperative disability
in pediatric patients operated for pilocytic astrocytomas,
Moshel et al. [7] used a diffusion tensor imaging (DTI)-based
ﬁbertracking and intraoperative neuronavigation. It resulted
in markedly lower incidence of postoperative motor deﬁcits.
Hou et al. [8] described eight different types of tumors based on
their location within the thalamus or subcortical nuclei and
relation to the surrounding anatomical structures, documen-
ted on DTI. It enabled them to accurately identify the posterior
limb of the internal capsule and its relation to the thalamic
mass. The use of this approach was reﬂected by markedly
lower incidence of postoperative limb hemiplegia and hemi-
paresis [8]. Also transcranial electrical stimulation (TES) and
intraoperativemapping of the internal capsule based on direct
electrical stimulation (DES) were shown to prevent postopera-
tive hemiparesis in patients with thalamic tumors [14–17].
The aims of this study were: (1) to explore if preoperative
hemiparesis results from neoplastic inﬁltration of the corti-
cospinal tract ﬁbers (manifesting as decreased nFA) and is
associated with the size of thalamic tumor, (2) to verify if the
outcome of intraoperative TES and the result of intraoperative
DES of the subcortical white matter may be used to predict the
risk of postoperative hemiparesis, (3) to assess whether the
extent of resection has a signiﬁcant inﬂuence on progression
and survival time of patients with thalamic tumors.
2. Material and methods
38 subsequent patients with thalamic tumors, including 17
women (mean age 38 years, range 20–60 years) and 21 men
(mean age 35.7 years, range 30–65 years) were treated
surgically at the Department of Neurosurgery between 2007
and 2014. The patients were operated under general anesthe-
sia with the aid of a neuronavigation system (BrainLab AG,
Munich, Germany) used to visualize the eloquent areas of the
cortex identiﬁed on the basis of fMRI (i.e. sensorimotor cortex,
Wernicke's and Broca's areas) and tractography of the white
matter tracts (i.e. corticospinal tract and optic tract) with a
diffusion tensor imaging (DTI-MRI) and monitoring of motor
evoked potentials (MEPs). Mapping of the Broca's and the
Wernicke's areas was done so that postoperative speech
disorders could be maximally limited during surgical proce-
dure, especially in the case of left-sided tumors.
Monitoring of MEPs included application of transcranial
electrical stimulation (TES) and direct electrical stimula-
tion (DES) to visualize the course of the corticospinal
pathway within the internal capsule. The MEPs obtained by
means of TES were classiﬁed according to Neuloh et al. [18],
i.e. as stable, reversibly deteriorated, irreversibly deterio-
rated or completely lacking. The MEPs obtained during the
subcortical white matter DES were grouped as positive (in
cases of a high-amplitude recording from the upper and
lower limbs contralateral to the tumor) or missing (if the
intraoperative stimulation resulted in no electromyo-
graphic response).
The extent of resection was assessed according to Sawaya
et al. [19], i.e. based on the results of pre- and postoperative (up
to 72 h post-surgery) FLAIR-MRI. The extent of resection was
classiﬁed as: (1) gross total resection (GTR, >95%), (2) subtotal
resection (STR, 85–95%), or (3) partial resection (PTR, <85%).
The extent of resection was determined as percentage in
particular groups and themean value of the extent of resection
was also determined for the whole study group of patients.
Follow-up MRI spectroscopy and perfusion MRI were
carried out 6 months after surgery and then at 6-month
intervals. At the same time neurological examination was
performed postoperatively. We examined whether new
transient or permanent neurological deﬁcits, such as hemi-
paresis, homonymous hemianopia and speech disorders
18 months. Basing on our results, patients with glioma grade I/II according to WHO
classiﬁcation are the best candidates for surgical treatment of thalamic tumors. In this
group of the patients more often resection is radical, median time to progression and
survival time are longer than in patients with gliomas grade III and IV. Within a 7-year
follow-up none of the patients with GI/GII grade glioma died.
© 2018 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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appeared. The deﬁcits were considered transient if they
resolved within six months after surgery, or permanent if
persisted longer than six months after surgery. The assess-
ment of paresis was done by an independent neurologist and
was carried out using the NIHSS scale [20].
The prognosis was analyzed in terms of: (1) median time to
progression (TTP), (2) median survival time (OS).
MRI of the brain was performed with a 1.5-T Magnetom
Avanto (Siemens AG, Erlangen, Germany) and 3-T Achieva
(Philips Medical Systems, Best, Netherlands) scanners with
standard coils for the examination of the head. Tumor
volumes were measured on FLAIR MRI scans. Measurements
of hyperintense regions were made in three orthogonal
dimensions. The volume of the tumor was extrapolated to
ellipsoid. Mean diffusivity (MD) maps, fractional anisotropy
(FA) maps in a gray scale, color-coded FA maps and
tractography were obtained using a software provided by
the MRI system manufacturers. Resolution (~2 mm) men-
tioned in the paper concerns DTI sequence.
MEPs were obtained with a 16-channel ISIS apparatus
(Inomed, Teningen, Germany). TES was performed with the
electrodes screwed or inserted into the points C3 and C4
(eventually M3 and M4) of the scalp skin. DES was conducted
with a bipolar Galanda probe and double-needle receiver
electrodes placed in the muscles. The receiver electrodes for
the MEP recording in contralateral limbs were placed in the
thenar and hypothenar of the upper extremity and interior
tibial muscle and triceps surae muscle of the lower extremity.
The control electrode was placed in the thenar of the upper
limb ipsilateral to the tumor. Monitoring of MEPs requires
veriﬁcation of control TES recordings from the ipsilateral limb;
this ensures that a potential loss of MEP from the contralateral
limb results from an injury to the corticospinal tract rather
than from problems with anesthesia or technical drawbacks.
In the case of DES, transcranial stimulation needs to be
performed periodically in order to ensure whether a potential
lack of MEP after the direct stimulation is truly a consequence
of the corticospinal tract injury rather than an effect of
stimulating the white matter that lacks motor ﬁbers.
Stimulation parameters were used during the MEP
recording – a train stimulation: impulses applied every 2–
3 s, each containing 4–6 pulses of 0.5 ms at 3–4 ms intervals,
300–700 V voltage and 100–150 mA (max. 220 mA) current (in
the case of TES) or 120–180 V voltage and 3–30 mA current
(DES). Typically, a 10–15 mA current in DES was used. The
MEP recordingswere considered stable if nomore than a 50%
increase in the baseline 100–150 mA current was required to
maintain the response. Also a decrease in the amplitude
down to 50% was considered a stable recording. A deteriora-
tion of MEP corresponded tomore than a 50% decrease in the
amplitude of electromyographic recording in relation to the
baseline recording. The loss of recording was deﬁned as the
lack of MEP at the highest current. Other researchers also
used bipolar electrical stimulation [14–16,21–23]. The inten-
sity of the stimulating current which these authors used
ranged from 2 to 16 mA. It is more difﬁcult to obtain a
response from the corticospinal tract using bipolar electrical
stimulation as compared to the monopolar electrical
stimulation. Higher electrical current is necessary in
patients with general anesthesia as compared to patients
recovered from anesthesia. The use of anesthetic gases,
barbiturates and relaxants is contraindicated during theMEP
monitoring. An optimal protocol of anesthesia includes
propofol and opioids in continuous infusion.
2.1. Statistical analysis
Statistical analysis was performed using the STATISTICA 10
software. Distributions of quantitative variables were checked
using the Shapiro–Wilk test. The Mann–Whitney U test was
used to evaluate differences between the variables. Probability
of survival and tumor progression over time were calculated
according to the Kaplan–Meier method and Kaplan–Meyer
curves for patients with particular clinical features (i.e. mode
of treatment or grade of tumor malignancy) were tested with
the log rank test.
The study was reviewed and approved by the Bioethics
Committee of Medical University of Silesia. Our Bioethics
Committee approved the study concerning surgical treatment
of adult patients with thalamic tumors (March 2008). Written
informed consent was obtained from all study participants.
3. Results
38 patients underwent surgical treatment of thalamic tumors.
In 30 cases (79%) the tumorwas located on the right side and in
8 (21%) on the left side. In 25 (66%) patients the tumors involved
solely the thalamus, and in 13 (34%) both the thalamus and
mesencephalic peduncles. The mean follow-up of the group
was 3.02 years.
The following approaches were used for surgical proce-
dures: postero-inferior temporal approach in 16 (42%) patients;
pterional, transcortical, transventricular approaches in 8
(21.1%) patients; posterior interhemispheric parasplenial
approach in 4 (10.5%) patients; pterional, transsylvian,
transinsular approach in 4 (10.5%) patients; superior parietal
gyrus approach in 2 (5.3%) patients; postero-inferior trans-
choroidal ﬁssure approach in 2 (5.3%) patients; transfrontal
stereotactic biopsy in 2 (5.3%) patients.
The choice of a surgical approach was based on the tumor
location within the anterior, posterior, dorsal or ventral
thalamus and topography of the internal capsule. Anterior
(via the anterior horn of the lateral ventricle), superior (via the
superior parietal lobule) and posterior (via the interhemi-
spheric ﬁssure and precuneus) approaches were used only if
the internal capsule was located laterally from the thalamic
mass. Lateral approaches (via the middle temporal gyrus
behind the sublenticular portion of the internal capsule or via
the choroidal ﬁssure or insula) were used only when the
internal capsule was located anteriorly or medially from the
mass.
Below are two examples of qualiﬁcations to a particular
surgical approach, depending on the location of the internal
capsule (Fig. 1).
Magnetic resonance images of a patient with a large right-
sided tumor in the thalamus and in the mesencephalic
peduncle. The sagittal and axial magnetic resonance scans
show that the internal capsule (yellow arrow) is located
posteriorly from the tumor. The transinsular approach
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through the lenticular nucleus was adoptedwith the intention
to spare the internal capsule (Fig. 2).
Postoperative magnetic resonance scans of a patient. Total
tumor resection. The internal capsule (yellow arrow) is spared.
Histopathological investigation revealed pilocytic astrocyto-
ma (Fig. 3).
Magnetic resonance images of a patient with a right-sided
posterior thalamic tumor. The internal capsule is located
medially and anteriorly from the tumor. Interhemispheric
parasplenial approachwas adopted. As a result, the patient did
not present with postoperative paresis or hemianopia. Histo-
pathological investigation revealed anaplastic astrocytoma.
In order to conﬁrm the presence of conduction within the
corticospinal tract and to identify the localization of the
posterior limb of the internal capsule, we recorded MEPs
obtained during intraoperative TES and DES of the subcortical
white matter. In patients who did not present with postoper-
ative hemiparesis, stable MEP recordings were obtained both
prior to and after surgery. In contrast, irreversible deterioration
of MEP recordings was documented intraoperatively in
patients who presented with NIHSS grade 2 postoperative
hemiparesis, despite the presence of normal preoperativeMEP
recordings from the operated hemisphere (Fig.4).
Preoperative motor evoked potential (MEP) response to
transcranial electrical stimulation (TES) in a patient who
developed postoperative hemiparesis ( [144_TD$DIFF] ig.5).
Irreversible deterioration of motor evoked potential (MEP)
response to transcranial electrical stimulation (TES) in a
patient who developed permanent postoperative hemiparesis.
As seen in the ﬁgures, irreversible deterioration of the
electromyographic recording was documented intraopera-
tively, which eventually was associated with the development
of contralateral hemiparesis postoperatively.
Relationships between the type of MEP recording obtained
during TES and DES and the incidence of postoperative
hemiparesis in 35 patients surgically treated for thalamic
tumors are shown in Table 1. Intraoperative MEP examination
was not done in 3 patients.
[(Fig._1)TD$FIG]
Fig. 1 – Magnetic resonance images of a patient with a large right-sided tumor in the thalamus and in the mesencephalic
peduncle. The sagittal and axial scans show that the internal capsule is located posteriorly from the tumor. The transinsular
approach through the lenticular nucleus was adopted with the intention to spare the internal capsule (yellow arrow).
n e u r o l o g i a i n e u r o ch i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 7 2 0 – 7 3 0 723
As shown in the table, stable MEP recordings were
documented in 49% of the patients who did not develop
postoperative hemiparesis. A reversible deterioration of MEPs
was typical of patients with transient hemiparesis (17%) and
irreversible deterioration was observed virtually only in
individuals with permanent postoperative hemiparesis (28%).
During the stimulation of the subcortical white matter
(DES), positive MEPs corresponding to close proximity of the
internal capsule were recorded in 15 (43%) patients. Only one
of these patients presented with permanent hemiparesis, 2
(6%) experienced transient hemiparesis and 9 (26%) presented
without evidence of postoperative hemiparesis. It enabled us
to spare the internal capsule in 14 of 15(93%) patients thus
preventing permanent hemiparesis.
We compared neurological status of our patients on
admission and postoperatively. The results are presented in
Table 2.
Table 2 shows that preoperative hemiparesis was observed
in 18 (47%) patients of whom 11 patients presented with
paresis grade 1 and 7 with grade 2, according to the NIHSS
classiﬁcation. After 6 months paresis was still present in 11
(29%) patients. Four patients presented with paresis grade 1
(NIHSS), which allowed the patients to walk without assis-
tance. Among patients with permanent hemiparesis (grade 2,
NIHSS) 6 of 7 (86%) patients presented with postoperative
hemiparesis, which was of the same intensity as prior to the
surgery.
Preoperativehemianopiawas documented in 1 patient, and
newly-developed postoperative hemianopia in 3. In all these
cases, hemianopia did not resolve during follow-up and was
permanent.
1 patient presentedwith preoperative speechdisorders. In 4
patients aphasia was still observed 6 months after surgery. In
all of them, thalamic tumorswere located in the left, dominant
hemisphere. Preoperative and postoperative disorders of
superﬁcial and deep sensation were observed in 4 and 5
patients, respectively, with no tendency to resolve. A total of 4
patients reported headaches of marked severity prior to the
surgery. In 3 of these patients headache resolved after surgery.
Hydrocephalus was observed prior to surgery in 11 patients.
After a 6-month follow-up only 2 patients presented with
symptoms of hydrocephalus. Bleeding from the postsurgical
site was observed in 4 patients. In two of them, bleeding was
controlled successfullywith surgical evacuation of hematoma.
Two patients died after surgical procedure for thalamic
tumors (5.2%). One patient died postoperatively after the
occurrence of hematoma located in the postoperative site. The
cause of hematoma was disseminated intravascular coagula-
[(Fig._2)TD$FIG]
Fig. 2 – Postoperative magnetic resonance images of a patient. Total tumor resection. The internal capsule is spared. The
patient presented with postoperative paresis grade I (NIHSS).
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tion (DIC). Despite urgent surgical procedure and treatment
the patient died due to complications. Pulmonary embolism
was the cause of death of the other patient despite
antithrombotic treatment.
We veriﬁed if the volume of the thalamic tumor was
associated with the risk of preoperative hemiparesis (Table 3).
The study was related only to patients with glial tumors (36
patients). A statistically signiﬁcant difference was observed in
the tumor volume (MRI-FLAIR) between patients with and
without hemiparesis before operation ( p < 0.05). The tumor
volume was larger in a group of 16 patients with hemiparesis
before operation.
Moreover, we analyzed if the preoperative hemiparesis
observed in patients with thalamic tumors resulted from the
partial damage to the corticospinal tract ﬁbers associated with
neoplastic inﬁltration, calculating normal fractional anisotro-
py (nFA) in the posterior limb of the internal capsule
ipsilaterally and contralaterally to the tumor (16) (Table 4).
The subset of patients with preoperative hemiparesis
showed signiﬁcantly lower nFA in the posterior limb of the
internal capsule ipsilaterally to the mass than in the intact
hemisphere (p < 0.05). This phenomenon most likely corre-
sponded to the neoplastic inﬁltration of the internal capsule
[24].
Histopathological examination of surgical specimens
revealed the following histological types of thalamic tumors:
anaplastic astrocytoma (n = 16), multiform glioblastoma
(n = 1), anaplastic oligoastrocytoma (n = 1), malignant epen-
dymoma (n = 1), PNET (n = 1), pilocytic astrocytoma (n = 7),
ﬁbrillary astrocytoma (n = 4), oligoastrocytoma (n = 4), poly-
myxoid astrocytoma (n = 1), metastatic breast cancer (n = 1)
and lymphoma (n = 1).
The relationship between the prognosis and the histopath-
ological type of thalamic tumors according to the WHO
classiﬁcation is presented in Table 5. The table does not
contain the data for patients with non-glial thalamic tumors.
Among the patients with grade I/II progression was
observed in 3/13 (23%). In the group with grade III/IV it was
19/23 (83%).Median TTPwas 36months for patientswith grade
I/II, and 14 months with grade III/IV. The differences are
[(Fig._3)TD$FIG]
Fig. 3 – MRI of a patient with a right-sided posterior thalamic tumor. The internal capsule is located medially and anteriorly
from the tumor. Interhemispheric parasplenial approach was adopted. As a result, the patient did not present with
postoperative paresis or hemianopia.
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statistically signiﬁcant (log-rank test, p = 0.0002). The shortest
median time to progression concerned the patients with
malignant tumors of the thalamus.
None of the patients with grade I/II died. Among the
patients with grade III/IV 11 of 23 (48%) died. Median OSwas 60
months for patients with grade I/II and 18 months with grade
III/IV. It is a statistically signiﬁcant difference (log-rank test,
p = 0.002). Worse prognosis was observed for patients classi-
ﬁed as III/IV grade glioma.
The analysis of the extent of resection showed that GTR,
STR and PTR were achieved in 18 (47%), 9 (24%) and 11 (29%)
patients. Mean extent of resection was 100% in the group with
[(Fig._4)TD$FIG]
Fig. 4 – Preoperative motor evoked potential (MEP) response to transcranial electrical stimulation (TES) in a patient who
developed postoperative hemiparesis.
[(Fig._5)TD$FIG]
Fig. 5 – Irreversible deterioration of MEP response to TES in a patient who developed permanent postoperative hemiparesis.
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total resection and 89.4 % in the group with subtotal resection,
and 77.18% in the case of partial resection. Themean extent of
resection was 86.5% for all operated patients.
GTR was achieved in 6 of 7 (85.7%) patients with pilocytic
astrocytoma, 4 of 8 (50%) subjects with ﬁbrillary astrocytoma
or oligoastrocytoma, and 8 of 23 (35%) with anaplastic
astrocytoma or multiform glioblastoma.
The relationship between the prognosis and the extent of
tumor resection is presented in Table 6. The table does not
contain the data for patients with non-glial thalamic tumors.
Among the patients with GTR progression was observed in
7/18 (39%), in a group with STR in 4/7 (57%) and in PTR in all 11
patients (100%). A statistically signiﬁcant difference is ob-
served between the extent of tumor resection and time to
progression (p = 0.0004).
The mortality rates were as follows: GTR – 2/18 (11%), STR –
1/7 (14%) and PTR – 8/11 (72%). There is a statistically signiﬁcant
difference between patients with different extent of resection
with respect to survival time (p < 0.05). Worse prognosis was
related to patients with partial tumor resection (PTR).
Table 1 – Prognostic value of transcranial electrical stimulation (TES) and direct electrical stimulation (DES) in prediction of
transient and permanent postoperative hemiparesis.
Stimulation Outcome Transient hemiparesis Permanent hemiparesis Lack of hemiparesis p-Value
TES Stable 0 (0%) 0 (0%) 17 (49%) <0.05
Reversible deterioration 6 (17%) 1 (3%) 0 (0%) –
Irreversible deterioration 1 (3%) 10 (28%) 0 (0%) –
DES Positive response 5 (14%) 1 (3%) 9 (26%) –
Missing response 2 (6%) 10 (28%) 8 (23%) –
Table 2 – Incidence of neurological symptoms in patients with thalamic tumors scheduled for surgical treatment.
Symptom Prior to surgery 6 months post-surgery
Mean age, years(range) 37 (20–65)
Male/female Male 36/female 38
Hemiparesis 18 (47%) 11 (29%)
- NIHSS grade 1 11 (29%) 4 (10.5%)
- NIHSS grade 2 7 (18%) 7 (18.5%)
Hemianopia 1 (3%) 4 (10.5%)
Speech disorders 1 (3%) 4 (10.5%)
Paresthesia 4 (10.5%) 5 (13%)
Headache 4 (10.5%) 1 (3%)
Hydrocephalus 11 (29%) 2 (5%)
Table 3 – Relationship between tumor volume and the incidence of hemiparesis in patients with thalamic tumors before
surgery.
Parameter No.Mean V ﬂair [cm3]Median V ﬂair [cm3]Minimum V ﬂair [cm3]Maximum V ﬂair [cm3]Std deviation
All patients 36 35.2 26.5 6.8 150.2 29.1
Lack of hemiparesis before operation 20 21.2 13.1 6.8 63.6 17.8
Hemiparesis before operation 16 52.7 45.3 18.8 150.2 31.5
p < 0.05.
Table 4 – Relationship between the incidence of hemiparesis and mean nFA in the posterior limb of the internal capsule
ipsilaterally and contralaterally to the tumor before operation.
Parameter Hemiparesis (n = 16) Lack of hemiparesis (n = 20) p-Value
nFA ipsilaterally 0.838  0.0904 0.951  0.084 <0.05
nFA contralaterally 1 1 –
Table 5 – Progression and median survival time of the patients with WHO classification of glioma tumors.
Pathological grade Cases Mean age
Years (range)
Progression Median TTP Median survival time
n n % mths mths
WHO grade I/II 13 32 (20–65) 3 23 36 60
WHO grade III/IV 23 39 (20–62) 19 83 14 18
Time to progression ( p < 0.05).
Survival time ( p < 0.05).
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4. Discussion
A tendency to conservative treatment of thalamic gliomas
existed for many years. In 1995 Krouwer and Prados published
a study on 70 patients with thalamic astrocytoma who had
brain biopsy and underwent radio and chemotherapy [25]. The
mean time to progression was 11.7 months and the mean
survival time was 18 months. Sometime earlier Kelly et al.
reported satisfactory surgical treatment results of patients
with thalamic pilocytic astrocytoma [11]. Based on conserva-
tive treatment results of patients with thalamic astrocytoma
and the thymidine labeling index in the cancer tissue, Franzini
et al. tried to search for indications for surgical treatment.
Forty three percent of patients with thalamic tumor died
within 3 years. The mortality rate was 100% in a group of
patients with the thymidine label index >5% and only 20% in
patients with the index <5. Therefore, surgical treatment
should be considered in the ﬁrst group [26].
A number of surgeons use MEPs at the time of surgery of
low-grade and high-grade gliomas in order to prevent
postoperative hemiparesis [14–16,27]. The presence of con-
ductionwithin the corticospinal tract ﬁberswas veriﬁed on the
basis of TES. This test accurately reﬂects the risk of
postoperative hemiparesis associated with the conduction
disorders. None of the patients with stable MEP responses
developed postoperative hemiparesis, and an irreversible
deterioration of MEP turned out to be associated with the
incidence of postoperative hemiplegia in 90% of cases. Zhou
and Kelly [28] analyzed MEPs in a group of 50 patients and
showed that an irreversible deterioration of the response,
namely a 50% decrease in the amplitude, is associated with
higher incidence of permanent hemiplegia. According to these
authors, transcranial mapping of MEPs is a safe and valuable
method for the detection of the corticospinal tract conduction
disorders in patients operated on for the brain tumors. Neuloh
et al. [18] did not observe postoperative hemiparesis in any of
the patients with insular tumors and stable MEP responses,
and documented the presence of hemiparesis in most
individuals presenting with an irreversible deterioration of
MEP response.
Moreover, we used bipolar DES of the subcortical white
matter to identify the posterior limb of the internal capsule.
Direct stimulation of the subcortical white matter enabled us
intraoperative identiﬁcation of the internal capsule in 43% of
cases. We classiﬁed the MEP recordings as positive responses
from the contralateral limb. Electrical current used for the
stimulation in our patients ranged between 10 mA and 15 mA.
We did not apply lower current as bipolar stimulation used in
this study is less likely to induce a response from the upper
and lower extremity muscles as compared to the monopolar
stimulation [27]. Surgical procedure was more cautious
whenever a positive response was obtained from the white
matter tracts located in the vicinity of the internal capsule.
Resectionwas performedat a slower pace and that stimulation
was constantly repeated. Identiﬁcation of the internal capsule
at surgery enabled us to save internal capsule thus preventing
hemiparesis in 14/15 (93%) patients.
Eighteen patients included in our series (47%) presented
with hemiparesis prior to the surgery. Similarly high incidence
of hemiparesis in patients with thalamic tumors was
previously reported by Nishio et al. [29]. Also other authors
conﬁrmed that the incidence of preoperative hemiparesis in
patients with thalamic tumors is quite high, ranging between
33% and 87% [5,7,9,10]. Hemiparesis was signiﬁcantly more
frequent among patients with large thalamic tumors and
turned out to be associated with lower mean nFA in the
internal capsule ipsilaterally to themass. All the patients with
preoperative evidence of hemiparesis showed its exacerbation
during the postoperative period. Six months following surgery
11 patients (29%) presented with the permanent disability.
However, this group included four patients with minor
hemiparesis (corresponding to NIHSS grade 1), thus being
capable of relatively independent functioning. In 6 of the 7
remaining patients paresis was observed preoperatively
mainly in patients with anaplastic astrocytoma. According
to Sai Kiran et al. [9], preexisting hemiparesis in patients with
anaplastic astrocytoma never resolves postoperatively, as
opposed to patients with pilocytic astrocytoma. According to
these authors, preoperative hemiparesis does not resolve after
surgery if the internal capsule is inﬁltrated by cancer cells [9].
In our series, preoperative hemiparesis did not usually resolve
in patients who presented with lower mean nFA in the
posterior limb of the internal capsule at the baseline. Also the
incidence of permanent postoperative hemiparesis was the
highest in this group. Therefore, the risk of permanent
postoperative hemiparesis does not seem to be associated
solely with the histopathological type of thalamic tumor. One
previous study showed that the risk of the permanent
hemiparesis is greater in patients in whom anaplastic
astrocytoma inﬁltrates the internal capsule, while similar
phenomenon is not observed in patients with pilocytic
astrocytoma [31].
Planning surgery, we aimed at sparing the optic radiation.
We achieved this objective due to preoperative identiﬁcation
of the optic tract topography by means of DTI and further
intraoperative visualization in the neuronavigation system.As
a result, only 8% patients from our series developed perma-
Table 6 – Effect of extent of resection on progression and survival.
Cases Progression Median TTP Median survival time
n N % mths mths
GTR (mean range of resection – 100%) 18 7 39 24 31
STR (mean range of resection – 89.4%) 7 4 57 26 32
PTR (mean range of resection – 77.18%) 11 11 100 9 12
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nent postoperative hemianopia. This likely reﬂected the fact
that the topography of the optic radiation was visualized
intraoperatively with the neuronavigation system. According
to Baroncini et al. [6], hemianopia constitutes the most
common complication of surgery for thalamic tumors in
children. It occurred in 7 (44%) of 16 operated patients. Steiger
et al. [5] reported postoperative visual impairment in 20% of
adult patients undergoing thalamic tumor resection.
The prognosis in patients with thalamic tumors is deter-
mined, to a large extent, by histopathological diagnosis. None
of our 13 patients withWHO grade I or II gliomas died during a
7-year follow-up, as compared to 55% mortality among those
with WHO grade III or IV gliomas. None of the patients with
malignant astrocytomas included in another series survived
three years post-surgery [31]. In another study, the 16-year
mortality rate of children operated on for WHO grade III or IV
thalamic gliomas amounted to 73%. However, three patients
from this group survived at 2, 3 and 16 years post-surgery,
respectively [30]. According to Kelly [11], patientswith grade IV
astrocytoma may survive, on average, up to 1.5 years post-
surgery. Steiger et al. [5] reported progression or recurrence in
60% of their patients diagnosed with WHO grade III or IV
gliomas. According to Sai Kiran et al. [9], grade III or IV thalamic
gliomas have a worse prognosis than their equivalents arising
in other parts of the CNS. In turn, Cuccia and Monges [32]
reported that the outcomes in patients operated on for
anaplastic astrocytomas of the thalamus are better than in
individuals subjected to biopsy and irradiation. Similar
ﬁndings were reported by Kelly [11] who analyzed the group
of patients with glioblastomamultiforme. Favorable prognosis
in patients with low-grade thalamic gliomaswas conﬁrmed by
Puget et al. [12] andAlbright [30]. It substantiates the surgery of
patientswith thalamic astrocytoma,whichweperformedwith
good results in 6 patients.
In contrast, Waqar et al. [33] showed that median survival
of patients with low-grade gliomas arising from the cerebral
midline structures, including the thalamus, was shorter than
in the case of lobar low-grade gliomas.
The extent of tumor resection constitutes a signiﬁcant
prognostic factor. In our series, the longest survival was
documented in the case of individualswhoachievedGTR. Sai
Kiran et al. [9] achieved total or subtotal resection in 64% of
patientswithWHOgrade I tumors, aswell as in 100%and 41%
of individuals withWHO grade II and III gliomas, respective-
ly. We achieved GTR in 47% of patients from our cohort,
whereas STR and PTR were achieved in 24% and 29% of the
subjects, respectively. The number of GTRs in patients with
grade I and II gliomas was signiﬁcantly higher than in
individuals with the grade III and IV tumors. In the study
conducted by Steiger et al. [5], the extent of resection
assessed on the basis of postoperative MRI corresponded to
80–100% in 11 (78.5%) cases. During a 4-year follow-up, a
progression or recurrence ofmalignant gliomawas observed
in 60% of the cases [5]. In another study, more than 90%
resectionwas achieved in 83% of pediatric patients [29]. Also
Moshel et al. [7] reported achieving GTR in 80% of children
with thalamic pilocytic astrocytomas. A signiﬁcant role of
the extent of resection as a determinant of prognosis in
patients with thalamic tumors was also emphasized by
French authors [12].
In our study we demonstrated that none of the patients
withWHO grades I and II gliomas died in the follow-up period.
Tumor progressionwas observed only in 3 of 13 (23%) patients.
Radical resection was the most frequently done in these
patients and mildly expressed hemiparesis occurred only in 2
patients. It seems that these patients should ﬁrst undergo
surgical treatment with the use of brain mapping and
neuromonitoring.
Time to progression in patients with grades III or IV gliomas
was 14months, which, to some extent, would substantiate the
performed surgical procedures. The median survival time was
18 months.
5. Conclusions
1 The preoperative volume of tumor in patients with hemi-
paresis is signiﬁcantly larger than in patients with lack of
hemiparesis. Hemiparesis is the result of the neoplastic
inﬁltration of the posterior limb of the internal capsule
(decreased mean nFA).
2 Transcranial electrical stimulation (TES) helps to predict
postoperative paresis of extremities.
3 Direct electrical stimulation (DES) is an effective tool for
intraoperative localization of the internal capsule thus
helping to avoid postoperative deﬁcit.
4 The extent of resection heavily inﬂuences the prognosis of
patients with thalamic tumors. Progression of patients with
WHO grades I and II is substantially longer than gliomas
grade III/IV. Median survival timewas 60months for grade I/
II and 18 months for grade III/IV.
5 Basing on our results, the patients with grade I/II (WHO
classiﬁcation) are the best candidates for surgical treatment
of thalamic tumors. More often resection is radical, median
time to progression and survival time are longer than in
patientswith gliomas grade III and IV.Within a 7-year follow
up none of the patients with GI/GII grade glioma died.
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